These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3098255

  • 1. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P, Schmitz HD, Weihrauch TR, Kuhlmann J.
    Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
    Demol P, Wingender W, Weihrauch TR, Graefe KH.
    Arzneimittelforschung; 1985 Sep; 35(5):861-3. PubMed ID: 3927929
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
    Shriver DA, Rosenthale ME, Kluender HC, Schut RN, McGuire JL, Hong E.
    Arzneimittelforschung; 1985 Sep; 35(5):839-43. PubMed ID: 3927928
    [Abstract] [Full Text] [Related]

  • 4. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
    Müller P, Dammann HG, Simon B.
    Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
    [Abstract] [Full Text] [Related]

  • 5. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB, Shriver DA, Tobia AJ, Rosenthale ME.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [Abstract] [Full Text] [Related]

  • 6. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
    Dammann HG, Rehner M, Walter TA, Müller P, Simon B.
    Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
    [Abstract] [Full Text] [Related]

  • 7. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
    Baunack AR, Froese G, Demol P, Wargenau M, Ruoff HJ, Weihrauch TR.
    Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
    [Abstract] [Full Text] [Related]

  • 8. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers.
    Tolman KG, Detweiler MK, Harrison CA, Rollins DE, Simon DA, Brady C, McCormack GH, Bryant EC.
    J Clin Pharmacol; 1988 Jan; 28(1):76-80. PubMed ID: 3127431
    [Abstract] [Full Text] [Related]

  • 9. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
    Morris GP, Keenan CM, Shriver DA.
    Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
    [Abstract] [Full Text] [Related]

  • 10. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G, Janssens J.
    Scand J Gastroenterol Suppl; 1989 May; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [Abstract] [Full Text] [Related]

  • 11. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
    Eichler HG, Korn A, Businger JA, Waldhäusl WK.
    Arch Int Pharmacodyn Ther; 1989 May; 298():288-92. PubMed ID: 2502955
    [Abstract] [Full Text] [Related]

  • 12. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M, Passaretti S, Tittobello A, Fasani R.
    Clin Ther; 1986 May; 8(6):619-23. PubMed ID: 3098425
    [Abstract] [Full Text] [Related]

  • 13. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
    Cohen A, Tolman KG, Lewis GP, Brown S, van Horn A, McCormack GH, Simon DM.
    Scand J Gastroenterol Suppl; 1989 May; 164():81-90; discussion 90-1. PubMed ID: 2510286
    [Abstract] [Full Text] [Related]

  • 14. Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
    Katz LB, Shriver DA.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):774-81. PubMed ID: 2509683
    [Abstract] [Full Text] [Related]

  • 15. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
    Bergmann JF, Simoneau G, Naudin R, Caulin C, Segrestaa JM.
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
    Simon B, Dammann HG, Müller P.
    Klin Wochenschr; 1986 Feb; 64 Suppl 7():44-6. PubMed ID: 3104657
    [Abstract] [Full Text] [Related]

  • 17. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
    Shriver DA, Katz LB, Rosenthale ME.
    Scand J Gastroenterol Suppl; 1989 Feb; 164():10-20. PubMed ID: 2510252
    [Abstract] [Full Text] [Related]

  • 18. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
    Demol P, Wingender W, Kuhlmann J.
    Scand J Gastroenterol Suppl; 1989 Feb; 164():68-71; discussion 71-2. PubMed ID: 2510284
    [Abstract] [Full Text] [Related]

  • 19. The effects of rioprostil on gastric emptying and intragastric acidity.
    Penston JG, Johnston DA, Wormsley KG.
    Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
    [Abstract] [Full Text] [Related]

  • 20. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
    Svendsen LB, Stener Jørgensen F, Hart Hansen O, Johansen A, Horn T, Larsen JK.
    Digestion; 1987 Jun; 37(1):29-34. PubMed ID: 3111919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.